17336
4-(2-氨基保护羧基)苯甲酸
≥95.0% (HPLC)
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C22H18N2O4
化学文摘社编号:
分子量:
374.39
UNSPSC Code:
12352200
NACRES:
NA.26
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
8082614
InChI
1S/C22H18N2O4/c25-21(26)14-9-11-15(12-10-14)23-24-22(27)28-13-20-18-7-3-1-5-16(18)17-6-2-4-8-19(17)20/h1-12,20,23H,13H2,(H,24,27)(H,25,26)
SMILES string
OC(=O)c1ccc(NNC(=O)OCC2c3ccccc3-c4ccccc24)cc1
InChI key
MLVJMSRGLQCZDE-UHFFFAOYSA-N
assay
≥95.0% (HPLC)
reaction suitability
reaction type: solution phase peptide synthesis, reagent type: linker
impurities
≤1% water, ≤5% residual solvent
application(s)
peptide synthesis
functional group
Fmoc
storage temp.
2-8°C
存储类别
11 - Combustible Solids
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
Michele Filippo Buono et al.
Cells, 9(7) (2020-07-24)
Genetic cardiomyopathies are characterized by changes in the function and structure of the myocardium. The development of a novel in vitro model could help to better emulate healthy and diseased human heart conditions and may improve the understanding of disease
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持